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Abstract: 
Cytokines play an important role in the evolution of inflammatory processes. Therefore, they are also key components of the cancer evolution, a disease 
recognized to depend on chronic inflammation. On the whole, we define cytokinome as the totality of these proteins and their interactions in and around 
biological cells. Understanding the complex interaction network of cytokines in patients affected from cancers should be very useful both to follow the 
cancer evolution from its early steps and to define innovative therapeutic strategies by using systems biology approaches. 
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Background & Description: 
Inflammation is a physiological process in response to acute tissue damage 
resulting from physical injury, ischemic injury, infection, exposure to 
toxins, chemical irritation, and/or other types of trauma. Moreover, it is a 
protective attempt by the organism to remove the injurious stimuli as well 
as initiate the healing process for the tissue. Inflammation may become 
chronic when an inflammatory stimulus persists. Some authors have 
suggested the correlation between chronic inflammation and cancer. In 
fact, while the inflammatory diseases increase the risk of developing many 
types of cancer, some non-steroidal anti-inflammatory drugs reduce this 
risk for certain cancers (for example, breast cancer) as well as their 
mortality. Interestingly, inflammation is involved in all three stages of 
tumor development: initiation, progression and metastasis. 
 
Cytokines are among molecules that play an important role in the evolution 
of these processes. They are proteins that are expressed before and during 
the inflammatory process and play a key role at the various disease levels 
so that they can be considered as specific markers of cancer and of its 
specific evolutive steps [Figure 1]. It is now clear that these proteins 
profoundly alter the metabolic pathways and, therefore, the homeostasis of 
the organism.  
 
In order to understand the whole universe of human cytokines, the so-
called cytokinome, according the “omics” system of definition, it needs to 
evaluate these proteins and analyse their complex network of interactions 
by which they regulate their own synthesis or that of their receptors, and 
antagonize or synergize with each other in many and often redundant ways. 
A major effort is the achievement of an efficient database that can collect 
together correct ontologies, algorithms and tools of analyses, structural and 
“omics” data of cytokines and their receptors, metabolic pathways, and the 
whole interactome. Another intriguing problem related to the cytokine 
family and their receptors is the pleiotropy existing in the cytokine system, 
where one cytokine is able to activate various receptors and many different 
cytokines activate the same receptor. When the frame of the whole 
cytokine network will be known, we will have the possibility to create best 
and more efficient drugs against the cancer, most probably able to interact 
with the receptors rather than directly with the cytokine molecules because 
of their pleiotropic effect. Another element of complexity in the cytokine 
network is introduced also by the fact that some genes encoding cytokines 
can give rise to variant forms of cytokines (isoforms) by means of 
alternative splicing, yielding molecules with slight structural differences 
but biologically significant changes of activities. This explains why it is 
always useful to analyze the gene expression profile correlated to the 
cytokines. In fact, previous studies have identified important mutations in 
lung cancers, but they were primarily focused on a limited set of genes 
and, thus, provided a constrained view of the mutational spectrum. Recent 
cancer sequencing efforts have used next-generation sequencing 
technologies to provide a genome-wide view of mutations in leukaemia, 
breast cancer and cancer cell lines. 
 
However, a correct and comprehensive understanding of cytokine 
functions can be obtained from simultaneous and coherent measurements 
of the serum concentrations of cytokines. This point raises the inherent 
difficulty of a simultaneous measurement of the cytokine concentrations to 
obtain correct internal ratios among the various molecules present in the 
same biological fluid due to the often large difference in concentrations 
spanning several magnitude orders. At present, it is possible to effectively 
characterize the serum levels of cytokines using a broad-spectrum bead-
based multiplex immunoassay. 
 
In this complex interactions network, Systems Biology and/or Biologically 
Integrated Approaches are powerful tools to analyze as a whole, the 
enormous amount of data coming from the so-called "omics" disciplines 
(genomics, transcriptomics, proteomics) by computational methods and 
algorithms, in order to create an information body that allows us to have a 
comprehensive and integrated vision of the biological phenomenon under 
investigation. These datasets can be analyzed and modelled 
computationally by using graphs or networks connecting the various data 
groups (related to gene and protein expression obtained by microarrays and 
by multiplex biometric ELISA-based immunoassay) in terms of dynamic-
probabilistic maps of metabolic and/or physiological activities and/or 
pathogenetic pathways. Therefore, the definition and evaluation of a 
human cytokinome is an important future tool to analyze the interaction 
network of cytokines both in healthy individuals and in patients affected 
from a cancer. Using these computational models it will be easier and 
immediate to understand and investigate how the regression of a chronic 
inflammation process, by acting on the cellular populations of cytokines, 
can block the progression of the cancer and how this knowledge can be an 
useful prognostic and diagnostic tool for clinicians. 
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Figure 1: Relationship between inflammation, cytokines and cancer 
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